Drug profile · INN
acetylcysteine
ACETYLCYSTEINE
- US status
- approved
- Patents linked
- 8
- News articles
- 0
Quick answer
acetylcysteine (ACETYLCYSTEINE) is an FDA-listed pharmaceutical active ingredient. Associated with Regeneron Ireland Designated Activity Company (DAC). Route of administration: oral. Current US regulatory status: approved.
Key facts
Related patents
Search patents →-
US 10869846
N-acetylcysteine amide (NAC amide) in the treatment of diseases and conditions associated with oxidative stress
granted -
US 9327028
Acetylcysteine compositions and methods of use thereof
granted -
US 8993627
N-acetylcysteine amide (NAC amide) for the treatment of diseases and conditions associated with oxidative stress
granted -
US 8952065
Acetylcysteine composition and uses thereof
granted -
US 8937099
N-acetylcysteine amide (NAC amide) for the treatment of diseases and conditions associated with oxidative stress
granted -
US 8653061
Acetylcysteine composition and uses thereof
granted -
US 8399445
Acetylcysteine composition and uses thereof
granted -
US 8148356
Acetylcysteine composition and uses therefor
granted
Frequently asked questions
What is acetylcysteine?
acetylcysteine (ACETYLCYSTEINE) is an FDA-listed pharmaceutical active ingredient. Associated with Regeneron Ireland Designated Activity Company (DAC). Route of administration: oral. Current US regulatory status: approved.
What is the brand name for acetylcysteine?
ACETYLCYSTEINE is a marketed brand name for acetylcysteine. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of acetylcysteine?
acetylcysteine has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.